QA: Amicus Therapeutics INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2020_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 520,073,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 47,705,000
3 remainder_Assets 61,632,000
4 LiabilitiesCurrent 128,812,000
5 LiabilitiesNoncurrent 58,827,000
6 remainder_Liabilities 186,143,000
7 CostOfGoodsAndServicesSold 29,978,229
8 SellingGeneralAndAdministrativeExpense 372,783,083
9 ResearchAndDevelopmentExpense 298,705,339
10 remainder_Expenses 28,151,391
11 remainder_Revenues 167,097,762
12 remainder_NetIncome -23,849,521
13 remainder_ComprehensiveNetIncome 2,670,924
  yvar yval
0 Assets 850,207,000
1 Liabilities 373,782,000
2 Expenses 729,618,042
3 Revenues 167,097,762
4 StockholdersEquity 476,425,000
5 NetIncome -586,369,801
6 ComprehensiveNetIncome -585,034,339
7 BaseVar 1,073,612,624
8 EconomicCapitalRatiobeforeLimitedLiability 0.741
9 EconomicCapitalRatio 2.09

Edgar->Model Mapping

Feature Distribution

Change over Time